Controversies in proliferative vitreoretinopathy tamponade and pharmacologic adjuvants.
Young
Tara A
TA
Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.
D'Amico
Donald J
DJ
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use*; D005466:Fluorocarbons / Q000627:therapeutic use; D006801:Humans; D046911:Macromolecular Substances / Q000627:therapeutic use; D012163:Retinal Detachment / Q000188:drug therapy* / Q000209:etiology; D012827:Silicone Oils / Q000627:therapeutic use; D013459:Sulfur Hexafluoride / Q000627:therapeutic use; D014821:Vitrectomy / Q000379:methods; D018630:Vitreoretinopathy, Proliferative / Q000150:complications / Q000188:drug therapy*
D000277:Adjuvants, Pharmaceutic; D005466:Fluorocarbons; D046911:Macromolecular Substances; D012827:Silicone Oils; D013459:Sulfur Hexafluoride